Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder

Sleep Medicine Reviews

Volumn 6, Issue 4, 2002, Pages 253-265

  Stiasny, Karin ^a,c   Hermann Oertel, Wolfgang ^a   Trenkwalder, Claudia ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Center of Nervous Diseases   (Germany)

Author keywords

Dopamine agonist; Levodopa; Periodic limb movement disorder (PLMD); Periodic limb movements (PLM); Periodic limb movements in sleep (PLMS); Restless legs syndrome (RLS); Therapy

Indexed keywords

DOPA DECARBOXYLASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; OPIATE; LEVODOPA;

AROUSAL; CIRCADIAN RHYTHM; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HUMAN; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PERIODIC LIMB MOVEMENT DISORDER; PREVALENCE; RESTLESS LEGS SYNDROME; REVIEW; SENSORY DYSFUNCTION; SLEEP DISORDER; SYMPTOMATOLOGY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORPUS STRIATUM; PARASOMNIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULARIZATION;

CORPUS STRIATUM; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGONISTS; HUMANS; LEVODOPA; NOCTURNAL MYOCLONUS SYNDROME; RESTLESS LEGS SYNDROME; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0038644564     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1053/smrv.2001.0193     Document Type: Review

References (98)

1. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995; 10(5): 634-642.
2. Hening WA, Walters A, LeBroca C, Hirsch L, Dhar A, IRLSSG Mot. The International RLS Study Group Rating Scale: a reliable and valid instrument for assessing severity of the restless legs syndrome. Neurology 2001; 56(Suppl. 3): A4.
3. Wetter TC, Stiasny K, Winkelmann J, Buhlinger A, Brandenburg U, Penzel T et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999; 52: 944-950.
4. Stiasny K, Wetter T, Winkelmann J, Brandenburg U, Penzel T, Rubin S et al. Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 2001; (in press).
5. Trenkwalder C, Brandenburg U, Hundemer H-P, Lledo A, Quail D, Swieca J et al. A randomized long-term placebo-controlled multicenter trial of pergolide in the treatment of RLS - the PEARLSStudy. Neurology (abstract) 2001; in press.
6. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997; 12(1): 61-65.
7. Smith RC. Relationship of periodic movements in sleep (nocturnal myoclonus) and the babinski sign. Sleep 1985; 8: 239-243.
8. Atlas Task Force of the American Sleep Disorders Association. Recording and scoring leg movements. Sleep 1993; 16: 748-759.
9. Atlas Task Force of the American Sleep Disorders Association (ASDA). The International Classification of Sleep Disorders - Diagnostic and Coding Manual. Rochester, Minnesota; 1997.
10. Atlas Task Force of the American Sleep Disorders Association. Guilleminault C, chairman. EEG arousals: scoring rules and examples. Sleep 1992; 15: 173-184.
11. Pollmächer T, Schulz H. Periodic leg movements (PLM): their relationship to sleep stages. Sleep 1993; 16(6): 572-577.
12. Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Periodic limb movements in sleep in community-dwelling elderly. Sleep 1991; 14(6): 496-500.
13. Bixler EO, Kales A, Vela-Bueno A, Jacoby JA, S. S, Soldatos CR. Nocturnal myoclonus and nocturnal myoclonic activity in a normal population. Research Communications in Chemical Pathology and Pharmacology 1982; 36: 129-140.
14. Dickel MJ, Mosko SS. Morbidity cut-offs for sleep apnea and periodic leg movements in predicting subjective complaints in seniors. 1990; 13: 155-166.
15. Mendelson WB. Are periodic leg movements associated with clinical sleep disturbances? Sleep 1996; 19: 219-223.
16. Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: Rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol 1992; 32: 3-10.
17. Guilleminault C, Philip P. Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment). Sleep 1996; 19(9 Suppl): S117-22.
18. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992; 42: 1371-1374.
19. Askenasy JJM. Sleep in Parkinson's disease. Acta Neurol Scand 1993; 87: 167-170.
20. Gadot N, Costeff H, Harel S, Lavie P. Motor abnormalities during sleep in patients with childhood hereditary progressive dystonia, and their uneffected family members. Sleep 1989; 12: 233-238.
21. Wetter TC, Collado-Seidel V, Pollmächer T, Yassoudris A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and Multiple System Atrophy. Sleep 2000; 23(3): 361-367.
22. Ferrini-Strambi L, Filippi M, Martinelli V, Oldani A, Rovaris M, Zucconi M et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 1994; 125: 194-197.
23. Walters AS, Wagner M, Hening WA. Periodic limb movements as the initial manifestation of restless legs syndrome triggered by lumbosacral radiculopathy [letter]. Sleep 1996; 19(10): 825-826.
24. de Mello MT, Silva AC, Rueda AD, Poyares D, Tufik S. Correlation between K complex, periodic leg movements (PLM), and myoclonus during sleep in paraplegic adults before and after an acute physical activity. Spinal Cord 1997; 35(4): 248-252.
25. Lee MS, Choi YC, Lee SH, Lee SB. Sleep-related periodic leg movements associated with spinal cord lesions. Mov Disord 1996; 11: 719-722.
26. Walker SL, Fine A, Kryger MH. L-DOPA/carbidopa for nocturnal movement disorders in uremia. Sleep 1996; 19(3): 214-218.
27. Culpepper WJ, P. B, Shaffer JI. Time-of-night patterns in PLMS activity. Sleep 1992; 15: 306-311.
28. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of Restless Legs Syndrome in Adults. Arch Intern Med 2000; 160: 2137-2141.
29. Rothdach A, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population - The MEMO study. Neurology 2000; 52: 1064-1068.
30. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994; 17(8): 739-743.
31. Walters AS, Hickey K, Maltzman J, Verrico T, Joseph D, Hening W et al. A questionnaire study of 138 patients with restless legs syndrome: the "NightWalkers" survey. Neurology 1996; 46(1): 92-95.
32. Walters AS, Picchietti DL, Ehrenberg BL, Wagner ML. Restless legs syndrome in childhood and adolescence. Pediatr Neurol 1994; 11(3): 241-245.
33. Winkelmann J, Wetter TC, Collado-Seidel V, Gasser T, Dichgans M, Yassouridis A et al. Frequency and characteristics of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000; 23: 597-602.
34. Trenkwalder C, Seidel VC, Gasser T, Oertel WH. Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord 1996; 11(4): 389-394.
35. Stautner A, Stiasny K, Collado-Seidel V, Bucher SF, Oertel WH, Trenkwalder C. Comparison of idiopathic and uremic restless legs syndrome: results of a database of 134 patients. Mov Dis 1996; 11: 98.
36. Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology 1996; 47(6): 1435-1441.
37. Lazzarini A, Walters AS, Hickey K, Coccagna G, Lugaresi E, Ehrenberg BL et al. Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees. Mov Disord 1999; 14(1): 111-116.
38. Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, Oertel WH, Trenkwalder C. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 1998; 31(2): 324-328.
39. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23(3): 200-203.
40. Salih AM, Gray RE, Mills KR, Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol 1994; 33(1): 60-63.
41. McParland P, Pearce JM. Restless legs syndrome in pregnancy. Case reports. Clin Exp Obstet Gynecol 1990; 17(1): 5-6.
42. Winkelmann J, Wetter TC, Trenkwalder C, Auer D. Periodic limb movements in Syringomyelia ana Syringobulbia. Mov Disord 2000; 15: 752-755.
43. Rutkove SB, Matheson JK, Logigian EL. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve 1996; 19(5): 670-672.
44. Iannaccone S, Zucconi M, Marchettini P, FeriniStrambi L, Nemni R, Quattrini A et al. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord 1995; 10(1): 2-9.
45. Gemignani F, Marbini A, Di Giovanni G, Salih S, Terzano MG. Charcot-Marie-Tooth disease type 2 with restless legs syndrome. Neurology 1999; 52: 1064-1066.
46. Walters AS, Mandelbaum DE, Lewin DS, Kugler S, England SJ, Miller M et al. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Pediatric Neurology 2000; 22(3): 182-186.
47. Picchietti DL, England SJ, Walters AS, Willis K, Verrico T. Periodic limb movement disorder and restless legs syndrome in children with attentiondeficit hyperactivity disorder. J Child Neurol 1998; 13(12): 588-594.
48. Dressler D, Thompson PD, Gledhill RF, Marsden CD. The syndrome of painful legs and moving toes. Mov Disord 1994; 9(1): 13-21.
49. Polysomnography Task Force. American Sleep Dissorders Association Standards of Practice Committe. Practice parameters for the indications for polysomnography and related procedures. Sleep 1997; 20: 406-422.
50. Montplaisir J, Boucher S, Nicolas A, Lesperance P, Gosselin A, Rompre P et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord 1998; 13(2): 324-329.
51. Michaud M, Soucy JP, Chabli A, Lavigne G, Montplaisir J. Spect imaging of pre- and postsynaptic dopaminergic functions in patients with restless legs syndrome. Sleep 2000; 23(Suppl. 2): A129.
52. Staedt J, Stoppe G, Kogler A, Riemann H, Hajak G, Munz DL et al. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatry Clin Neurosci 1995; 245(1): 8-10.
53. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome 18F-dopa and 11C-raclopride PET studies. Neurology 1999; 52: 932-937.
54. Ruottinen HM, Partinen M, Hublin M, Bergmann J, Haaparanta M, Solin O et al. A F-DOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000; 54: 502-504.
55. Trenkwalder C, Walters AS, Hening WA, Chokroverty S, Antonini A, Dhawan V et al. Positron Emission Tomographic Studies in Restless Legs Syndrome. Mov Disord 1999; 14(1): 141-145.
56. San Pedro EC, Mountz JM, Mountz JD, Liu HG, Katholi CR, Deutsch G. Familial painful restless legs syndrome correlates with pain dependent variation of blood flow to the caudate, thalamus, and anterior cingulate gyrus. J Rheumatol 1998; 25(11): 2270-2275.
57. Bucher SF, Seelos KC, Oertel WH, Reiser M, Trenkwalder C. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 1997; 41(5): 639-645.
58. Trenkwalder C, Bucher SF, Oertel WH, Proeckl D, Plendl H, Paulus W. Bereitschaftspotential in idiopathic and symptomatic restless legs syndrome. Electroencephalogr Clin Neurophysiol 1993; 89(2): 95103.
59. Stiasny K, Haeske H, Müller H-H, Braune H-J, Oertel WH. Inhibition of motor circuits is impaired in restless legs syndrome. Mov Disord 2000; 15(Suppl. 3): 80.
60. Entezari-Taher M, Singleton JR, Jones CR, Meekins G, Petajan JH, Smith AG. Changes in excitability of motor cortical circuitry in primary restless legs syndrome [In Process Citation]. Neurology 1999; 53: 1201-1205.
61. Tergau F, Wischer S, Paulus W. Impaired motor cortex excitability in patients with restless legs syndrome. Neurology 1998; 50: A 223.
62. Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallet M. Periodic limb movements in sleep. State-dependent excitability of the spinal flexor reflex. Neurology 2000; 54: 1609-1615.
63. Tarquini B. Iron metabolism: clinical chronobiological aspects. Chronobiologica 1978; 5 (3): 315-336.
64. Early CJ, Connors JR, Allen RP. RLS patients have abnormal reduced CSF ferritin compared to normal controls. Neurology 1999; 52(Suppl. 2): A111-A112.
65. Allen RP, Barker PB, Wehrl F, Song HK, Early CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001; 56: 263-265.
66. Davis BJ, Rajput A, Rajput ML, Aul EA, Eichhorn GR. A randomized, double-blind, placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 2000; 43: 70-75.
67. Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep 1998; 21(5): 501-505.
68. Chesson AL, Wise M, Davila D, Johnson S, Littner M, Anderson M et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999; 22(7): 961-968.
69. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder - an American Academy of Sleep Medicine Review. Sleep 1999; 22(7): 970-998.
70. Trenkwalder C, Stiasny K, Pollmächer T, Wetter TC, Schwarz J, Kohnen R et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: A double-blind, crossover trial. Sleep 1995; 18(8): 681-688.
71. Collado-Seidel V, Kazenwadel J, Wetter TC, Kohnen R, Winkelmann J, Selzer R et al. A controlled study of additional SR-L-dopa in L-dopa responsive RLS with late night symptoms. Neurology 1999; 52: 285-290.
72. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996; 19(3): 205-213.
73. Walters AS, Hening WA, Kavey N, Chokroverty S, Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1988; 24(3): 455-458.
74. Stiasny K, Roebbecke J, Schüler P, Oertel WH. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline - an open clinical trial. Sleep 2000; 23(3): 349-354.
75. Saletu B, Gruber G, Saletu M, Brandstatter N, Hauer C, Prause W et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. I. Findings on objective and subjective sleep and awakening quality. Sleep Neuropsychobiology 2000; 41: 181-189.
76. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999; 52(5): 938-943.
77. Montplaisir J, Denesle R, Petit D. Pramipexole in the treatment of restless legs syndrome: a followup study. European J of Neurol 2000; 7(Suppl. 1): 27-31.
78. Stiasny K, Moeller JC, Oertel WH. Safety of pramipexole in patients with restless legs syndrome. Neurology 2000; 55(2): 1589-1590.
79. Benes H, DeiBler A, Clarenbach P, Rodenbeck A, Hajak G. Lisurid in the management of restless legs syndrome - an extended polysomnographic study. Mov Disord 2000; 15(Suppl. 3): 134.
80. Tergau F, Wischer S, Wolf C, Paulus W. Treatment of restless legs syndrome with α-dihydroergocriptine. Mov Disord 1998; 13(Suppl. 2): 292.
81. Evidente VGH, Adler CH, Caviness JN, Hentz JG, Gwinn-Hardy K. Amantadine is beneficial in restless legs syndrome. Mov Disord 2000; 15(2): 324-327.
82. Reuter I, Ellis CM, Chauduri KR. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Acta Neurol Scand 1999; 100(3): 163-167.
83. Walters AS, Wagner ML, Hening WA, Grasing K, Mills R, Chokroverty S et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993; 16(4): 327-332.
84. Allen RR Kaplan PW, Buchholz DW, Early CJ, Walters JK. Double-blinded, placebo controlled comparison of high dose propoxyphene and moderate dose carbidopa/levodopa for treatment of periodic limb movements in sleep. Sleep Res 1992; 21: 166.
85. Lauerma H, Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry 1999; 60(4): 241-244.
86. Walters AS, Winkelmann J, Trenkwalder C, Fry JM, Kataria V, Wagner M et al. Long-term opioid monotherapy in patients with restless legs syndrome. Mov Disord 2001; in press.
87. Telstad W, Sorensen O, Larsen S, Lillevold PE, Stensrud R Nyberg-Hansen R. Treatment of the restless legs syndrome with carbamazepine: a double blind study. Br Med J (Clin Res Ed) 1984; 288(6415): 444-446.
88. Zucconi M, Coccagna G, Petronelli R, Gerardi R, Mondini S, Cirignotta F. Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment. Funct Neurol 1989; 4(3): 263-271.
89. Laschewski P, Sanner B, Konermann M, Kreuzer I, Horstensmeyer D, Sturm A. Pronounced hypersomnia in a 13-year-old patient with periodic leg movements]. Pneumologie 1997; 51(Suppl. 3): 725-728.
90. Ehrenberg BL, Eisensehr I, Corbett KE, Crowley PF, Walters AS. Valproate for sleep consolidation in periodic limb movement disorder. J Clin Psychopharmacol 2000; 20: 574-578.
91. Adler CH. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol 1997; 20(2): 148-151.
92. Peled R, Lavie P. Double-blind evaluation of clonazepam on periodic leg movements in sleep. J Neurol Neurosurg Psychiatry 1987; 50: 1679-1681.
93. Horiguchi J, Inami Y, Sasaki A, Nishimatsu O, Sukegawa T. Periodic leg movements in sleep with restless legs syndrome: effect of clonazepam treatment. Jpn J Psychiatry Neurol 1992; 46(3): 727-732.
94. Braude W, Barnes T. Clonazepam: effective treatment for restless legs syndrome in uraemia [letter]. Br Med J (Clin Res Ed) 1982; 284(6314): 510.
95. Montagna P, Sassoli de Bianchi L, Zucconi M, Cirignotta F, Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984; 69(6): 428-430.
96. Guilleminault C, Flagg W. Effect of baclofen on sleep-related periodic leg movements. Ann Neurol 1984; 15: 234-239.
97. Wagner ML, Walters AS, Coleman RG, Hening WA, Grasing K, Chokroverty S. Randomized, doubleblind, placebo-controlled study of clonidine in restless legs syndrome. Sleep 1996; 19(1): 52-58.
98. Trenkwalder C, Brandenburg U, Hundemer HP, Lledo A, Quail D, Wood E, Swieca J, Polo O, Wetter TC, Strambi L, deGroen HJ, and the PEARLS Study Group A randomized long-term placebocontrolled multicenter trial of pergolide in the treatment of restless legs syndrome with central evaluation of polysomnographic data. Neurology 2001; 56 (Suppl 3): A5.